The grey market premium of the Augmont Enterprises IPO, day by day, against the ₹788 upper price band. Last figure from 31 Aug 2026.
The GMP of the Augmont Enterprises IPO started at ₹190 on 18 Aug 2026 and ended ₹290 before listing, up ₹100 over 14 days.
It peaked at ₹395 on 22 Aug 2026 and was lowest at ₹190 on 18 Aug 2026. In the last 4 days it fell by ₹11.
From one recorded day to the next, the GMP rose on 5 days, fell on 5 days and held on 3 days. The largest one-day move was a rise of ₹90 on 19 Aug 2026.
On the day bidding opened, 21 Aug 2026, the GMP was ₹310; on the day it closed, 25 Aug 2026, it was ₹315.
Bidding closed with the issue subscribed 111.18× overall.
At the ₹788 upper band, the last GMP pointed to a 36.8% gain; the shares listed up 21.95%, so the GMP overstated the gain.
One lot is 19 shares, ₹14,972 at the ₹788 upper band.
The last GMP pointed to a gain of ₹5,510 on one lot. The shares listed at about ₹960.97, which made a gain of ₹3,286 on one lot.
At the highest GMP, ₹395, the figure for one lot was a gain of ₹7,505; at the lowest, ₹190, it was a gain of ₹3,610.
GMP last updated: 31 Aug 2026, 9:29 AM IST
| Date | GMP | Over issue price | Implied listing | Change |
|---|---|---|---|---|
| 31 Aug 2026 | ₹290 | 36.8% | ₹1078 | – |
| 30 Aug 2026 | ₹290 | 36.8% | ₹1078 | +₹4 |
| 29 Aug 2026 | ₹286 | 36.29% | ₹1074 | −₹15 |
| 28 Aug 2026 | ₹301 | 38.2% | ₹1089 | – |
| 27 Aug 2026 | ₹301 | 38.2% | ₹1089 | −₹14 |
| 26 Aug 2026 | ₹315 | 39.97% | ₹1103 | – |
| 25 Aug 2026 | ₹315 | 39.97% | ₹1103 | −₹10 |
| 24 Aug 2026 | ₹325 | 41.24% | ₹1113 | −₹55 |
| 23 Aug 2026 | ₹380 | 48.22% | ₹1168 | −₹15 |
| 22 Aug 2026 | ₹395 | 50.13% | ₹1183 | +₹85 |
| 21 Aug 2026 | ₹310 | 39.34% | ₹1098 | +₹10 |
| 20 Aug 2026 | ₹300 | 38.07% | ₹1088 | +₹20 |
| 19 Aug 2026 | ₹280 | 35.53% | ₹1068 | +₹90 |
| 18 Aug 2026 | ₹190 | 24.11% | ₹978 | – |
GMP is an unofficial price from the grey market before the shares list. It is not a guarantee of the listing price and can move sharply from one day to the next. Read how we collect it in our methodology.